“…The key outcome measures reported across the studies included consumption of targeted antimicrobials and/ or associated costs 112,113,132,[114][115][116][117]122,123,128,131 , incidence of Clostridium difficile 112,113,[123][124][125]127,[114][115][116][117][119][120][121][122] or incidence and/ resistance rates of Klebsiella pneumoniae 128,129,144,[130][131][132][133][134]137,139,143 as well as risk on other HCAIs 114,121,123,127,130,137,139 . Additional outcomes included containment of an outbreak of the targeted organisms 135,136,138,[140][141][142]…”